MedPath

Platelet-Rich Fibrin in Intraoral Soft Tissue Regeneration

Not Applicable
Withdrawn
Conditions
Mucosal Ulceration
Interventions
Procedure: Platelet Rich Fibrin Application
Registration Number
NCT04022720
Lead Sponsor
University of Florida
Brief Summary

Determine if the use of platelet rich fibrin (PRF) improves the rate and quality of healing for intraoral mucosal and epithelial soft tissue defects.

Detailed Description

Not available

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  • Three categories of patients will be included in this study:

    1. Osteoradionecrosis (ORN) or medication related osteonecrosis of the jaw (MRONJ) patients who present to clinic with exposed bone and no clinical sign of infection.
    2. Patients having an excisional biopsy in clinic performed under local anesthesia resulting in a defect that cannot be easily repaired without compromising normal anatomy or function. These situations include excisions which would result in primary closure under tension or with distorted anatomy, require a local flap, or require healing by secondary intention.
    3. Patients presenting to the post-operative clinic with intraoral surgical wound dehiscence or an intraoral surgical wound healing by secondary intention.
Read More
Exclusion Criteria
  • Patients under 18 years of age.
  • Patient's unable to participate in blood draw either due to medical compromise, inability to tolerate the procedure, or inability of the physician to successfully draw the blood at the time of appointment.
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Platelet Rich Fibrin (PRF) GroupPlatelet Rich Fibrin ApplicationPatients randomized to this group will receive treatment with a PRF graft.
Primary Outcome Measures
NameTimeMethod
Change in rate of healing in intraoral mucosa and epithelium soft tissues3 months post-operatively

Improved healing times of PRF patients compared to control group.

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath